DP
OCGN icon

Diadema Partners’s Ocugen OCGN Stock Holding History

Diadema Partners’s Portfolio OCGN Stock Details OCGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$543K Buy
+300,000
New +$519K 0.09% 105

Other funds holding OCGN

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Diadema Partners's OCGN Position: Q1 2026 in Review

Diadema Partners opened a new position in Ocugen (OCGN) in Q1 2026: 200,000 shares worth $362K. The stake represents 0.06% of the portfolio and ranks #119 among its holdings.

137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

  • Diadema Partners held 200,000 shares of Ocugen worth $362K as of Q1 2026.
  • Ocugen was a new Diadema Partners position in Q1 2026.
  • Ocugen made up 0.06% of Diadema Partners's portfolio in Q1 2026, its #119 holding.
  • 137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.